摘要 |
The invention relates to novel ligands, the broad spectrum of which simultaneously comprises alpha-adrenoceptors, dopamine receptors, histamine receptors, imidazoline receptors and seratinin receptors, including 5-HT7 seratinin receptors, as compounds of general formula 1 in the form of free bases, geometrical isomers, racemic mixtures or individual optical isomers and also in the form of pharmaceutically acceptable salts and/or hydrates, wherein: R1 is an aminogroup substituent, optionally substituted C1-C2 alkyl, acyl, heterocyclyl, alkoxycarbonyl and substituted sulphonyl; R2 is a cyclic group substituent, including a hydrogen atom, a halogen atom, optionally substituted C1-C4 alkyl, CF3, CN, alkoxy, alkoxycarbonyl, carboxyl, heterocyclyl or substituted sulphonyl; Ar is optionally substituted aryl, possibly annelated with heterocyclyl, or optionally substituted heterocyclyl; W is an optionally substituted CH2-CH=CH group, an optionally substituted C=C group, an SO2 group; n=1 or 2; m=1, 2 or 3; a continuous line together with a dotted line following it (---) represent a single or a double bonds. Medicinal substances, pharmaceutical compositions containing the novel ligands in the form of medicinal substances, novel medicinal agents which are used for treating diseases and states of the central nervous system of human beings and animals, are also disclosed. |
申请人 |
IVASHCHENKO, ANDREY ALEXANDROVICH;ALLA CHEM, LLC;IVASHCHENKO, ALEXANDER VASILIEVICH;LAVROVSKY, YAN VADIMOVICH;MITKIN, OLEG DMITRIEVICH;SAVCHUK, NIKOLAY FILIPPOVICH;TKACHENKO, SERGEY YEVGENIEVICH;OKUN, ILYA MATUSOVICH |
发明人 |
IVASHCHENKO, ANDREY ALEXANDROVICH;IVASHCHENKO, ALEXANDER VASILIEVICH;LAVROVSKY, YAN VADIMOVICH;MITKIN, OLEG DMITRIEVICH;SAVCHUK, NIKOLAY FILIPPOVICH;TKACHENKO, SERGEY YEVGENIEVICH;OKUN, ILYA MATUSOVICH |